NCT03953508

Brief Summary

This study focuses on menthol (n = 125) and non-menthol (n = 125) smoking young adults (YAs; defined here as ages 18 to 26).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
199

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 13, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 16, 2019

Completed
1.2 years until next milestone

Study Start

First participant enrolled

August 1, 2020

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2023

Completed
1.9 years until next milestone

Results Posted

Study results publicly available

December 16, 2024

Completed
Last Updated

December 16, 2024

Status Verified

October 1, 2024

Enrollment Period

2.4 years

First QC Date

May 13, 2019

Results QC Date

November 13, 2023

Last Update Submit

October 30, 2024

Conditions

Outcome Measures

Primary Outcomes (5)

  • Subjective Response to Smoking Cigarettes From the Cigarette Evaluation Scale

    ratings of subjective satisfaction from smoking cigarettes, 1= not at all to 7 = extremely. Higher scores indicate greater positive subjective response. The minimum score is 1and the maximum score is 7.

    immediately after smoking usual brand cigarette, at baseline

  • Average Daily Subjective Response From Smoking

    average daily scores of subjective reward from smoking from daily diary surveys, 1= not at all to 7 = extremely. Higher scores indicate greater positive subjective response. Averaged across 14 days.

    Phase 2 daily diary surveys (estimated 2-4 weeks after baseline)

  • Highest Trial Competed for a Menthol Cigarette Puff in the Choice Task (Relative Reinforcing Value for Menthol Cigarettes)

    Participants completed a choice task assessing willingness to "work" to click targets on a computer screen to earn menthol or non-menthol cigarette puffs. The relative reinforcing value for menthol was defined by the Breakpoint, or the highest trial (out of 10 trials) completed for a menthol cigarette puff.

    Lab session 3 (estimated average 1-4 weeks after baseline)

  • Past 30-day Cigarette Smoking Frequency

    Number of days smoked cigarettes in the past 30-days

    6-month follow-up survey (6-months post-baseline)

  • Puff Topography

    Number of cigarette puffs after smoking one's preferred brand/flavor during lab session 1, Phase 1.

    Laboratory session 1 (up to 4 weeks after baseline)

Secondary Outcomes (5)

  • Number of Clicks for Menthol Cigarette Puffs on the Behavioral Choice Task

    immediately after completing the behavioral economic choice task, lab session 3 (estimated average 1-4 weeks after baseline)

  • Quantity of Past 30-day Tobacco Product Use

    6-month follow-up (6-months post-baseline)

  • Number of Participants With Intentions to Smoke Menthol Cigarettes

    6-month follow-up (6-months post-baseline)

  • Cigarettes Per Day

    Phase 2 daily diary surveys (estimated 2-4 weeks after baseline)

  • Average Daily Craving From Smoking

    Phase 2 daily diary surveys (estimated 2-4 weeks after baseline)

Study Arms (2)

Menthol

OTHER

Participants who prefer smoking menthol cigarettes

Other: Cigarette flavor type

Non-menthol

OTHER

Participants who prefer smoking non-menthol cigarettes

Other: Cigarette flavor type

Interventions

Participants will smoke several puffs (each) of a menthol Camel Crush and several puffs of a non-menthol Camel Crush cigarette.

Also known as: Experimental cigarette smoking
MentholNon-menthol

Eligibility Criteria

Age18 Years - 26 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Ages 18-26
  • Currently smoke cigarettes "everyday" or "somedays"
  • A strong preference for menthol or non-menthol cigarettes
  • able to read and understand the consent form
  • willingness to abstain from nicotine or tobacco products for at least 12 hours prior to smoking sessions

You may not qualify if:

  • Current use of nicotine replacement therapy
  • Pregnant or planning to become pregnant; or breastfeeding
  • self-reported diagnosis of lung disease, including asthma, cystic fibrosis, or chronic obstructive pulmonary disease; or
  • self-reported history of cardiac event or distress within the past 3-months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Health Promotion Research Center

Oklahoma City, Oklahoma, 73104, United States

Location

Related Publications (2)

  • Cohn AM, Elmasry H, Niznik T, Pickworth W, Smith MA, Margaritis WD, Wyatt R, Dunn D, Hedeker D, Murphy J, Audrain-McGovern J, Villanti AC. Racial and ethnic differences in topography and subjective effects among young adults in response to smoking their usual brand menthol or nonmenthol cigarette. Exp Clin Psychopharmacol. 2025 Apr;33(2):145-154. doi: 10.1037/pha0000765. Epub 2025 Feb 24.

  • Cohn AM, Pickworth W, Audrain-McGovern J, Murphy J, Villanti AC, Hedeker D, Dunn D, Wyatt R, Niznik T, Cotten W, Smith M, Ehlke SJ. Measuring young adult appeal for menthol and non-menthol cigarettes: protocol of a clinical trial using both laboratory and intensive longitudinal methods (PRISM). BMJ Open. 2022 Apr 28;12(4):e058823. doi: 10.1136/bmjopen-2021-058823.

MeSH Terms

Conditions

Cigarette Smoking

Condition Hierarchy (Ancestors)

Tobacco SmokingSmokingBehaviorTobacco Use

Limitations and Caveats

Data were collected during the COVID-19 pandemic, during times when there were complete or intermittent shut-downs in-person data collection. This resulted in some changes to the order of administration of the study periods/phases in the protocol.

Results Point of Contact

Title
Amy Cohn, PhD
Organization
University of Oklahoma Health Sciences Center

Study Officials

  • Amy Cohn, PhD

    University of Oklahoma

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 13, 2019

First Posted

May 16, 2019

Study Start

August 1, 2020

Primary Completion

December 31, 2022

Study Completion

January 31, 2023

Last Updated

December 16, 2024

Results First Posted

December 16, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations